secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001104659-24-111145
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel gets Nasdaq extension to Dec 24, 2024 to meet equity minimum
---------------------------------------------------------------------

- Nasdaq Hearing Panel granted until Dec 24, 2024 to regain compliance with Rule 5550(b)(1).
- Company had stockholders' equity below $2.5 million as of June 30, 2024.
- No assurance compliance will be met; delisting risk remains if not regained by deadline.
- Listing Council may review panel decision within 45 days of Oct 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924111145/0001104659-24-111145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465924111145/tm2426738d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-111145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer